Suppr超能文献

3C研究中血浆脂质与新发痴呆及痴呆亚型的差异关联:一项基于人群的纵向前瞻性队列研究

Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.

作者信息

Schilling Sabrina, Tzourio Christophe, Soumaré Aïcha, Kaffashian Sara, Dartigues Jean-François, Ancelin Marie-Laure, Samieri Cécilia, Dufouil Carole, Debette Stéphanie

机构信息

University of Bordeaux, Bordeaux, France.

Inserm U1219, Bordeaux, France.

出版信息

PLoS Med. 2017 Mar 28;14(3):e1002265. doi: 10.1371/journal.pmed.1002265. eCollection 2017 Mar.

Abstract

BACKGROUND

Vascular risk factors have been proposed as important targets for the prevention of dementia. As lipid fractions represent easily modifiable targets, we examined the longitudinal relationship of baseline lipid fractions with 13-y incident dementia and its subtypes (Alzheimer disease [AD] and mixed or vascular dementia) in older community-dwelling persons.

METHODS AND FINDINGS

Non-institutionalized persons aged 65+ y (n = 9,294) were recruited for the Three-City Study (3C Study), a population-based cohort study from the electoral rolls of the cities of Dijon, Bordeaux, and Montpellier, France, between March 1999 and March 2001. Follow-up examinations were performed every 2 y after the baseline assessment. The final study sample comprised 7,470 participants from the 3C Study (mean age ± standard deviation [SD] 73.8 ± 5.3 y, 61.0% women) who were prospectively followed up for up to 13 y. Fasting lipid fractions (triglycerides [TGs], high-density lipoprotein cholesterol [HDL-C], low-density lipoprotein cholesterol [LDL-C], total cholesterol [TC]) were studied as continuous variables, and results are reported per SD increase of each lipid fraction. Incident dementia and its subtypes were studied as censored variables using Cox models with age as time scale. Analyses were adjusted for sex, study center, and educational level, as well as vascular risk factors and apolipoprotein E (APOE) ε4 genotype. We corrected for multiple testing, yielding a significance threshold of 0.0169. p-Values above the significance threshold but less than 0.05 were considered nominally significant. During a mean (± SD) follow-up period of 7.9 ± 3.6 y, 779 participants developed incident dementia (n = 532 AD and n = 154 mixed or vascular dementia). Higher LDL-C and TC concentrations at baseline were associated with an increased risk of AD (hazard ratio [HR] per SD increase = 1.13 [95% CI 1.04-1.22], p = 0.0045, and HR = 1.12 [1.03-1.22], p = 0.0072, respectively). These associations were largely unchanged after adjustment for vascular risk factors and were attenuated after adjustment for APOEε4 (HR per SD increase = 1.12 [1.03-1.23], p = 0.0110, and HR = 1.12 [1.02-1.23], p = 0.0171, respectively). Higher TG concentrations at baseline were associated with an increased risk of all dementia (HR per SD increase = 1.11 [1.03-1.19], p = 0.0044) and mixed or vascular dementia (HR = 1.21 [1.04-1.41], p = 0.0163). However, these associations disappeared after adjusting for vascular risk factors (HR = 1.07 [0.98-1.17], p = 0.1374, and HR = 1.17 [0.96-1.42], p = 0.1206, respectively). Main limitations of the study include interval censoring of incident dementia cases, potential selective survival bias, and the fact that variation in lipid concentrations during follow-up could not be accounted for in the analyses.

CONCLUSIONS

In a large population-based sample of older community-dwelling persons with up to 13 y of follow-up, we observed that higher LDL-C and TC concentrations were associated with an increased risk of AD. This result was independent of vascular risk factors and was attenuated after adjustment for APOEε4 carrier status. TG and HDL-C concentrations were not associated with risk of incident dementia or its subtypes after accounting for vascular risk factors.

摘要

背景

血管危险因素已被视为预防痴呆症的重要靶点。由于血脂成分是易于调节的靶点,我们研究了老年社区居民基线血脂成分与13年痴呆症发病及其亚型(阿尔茨海默病[AD]以及混合型或血管性痴呆)之间的纵向关系。

方法与结果

从法国第戎、波尔多和蒙彼利埃市的选民名单中招募了年龄在65岁及以上的非机构化人员(n = 9294)参与三城市研究(3C研究),这是一项基于人群的队列研究,研究时间为1999年3月至2001年3月。基线评估后每2年进行一次随访检查。最终研究样本包括来自3C研究的7470名参与者(平均年龄±标准差[SD]为73.8±5.3岁,61.0%为女性),他们被前瞻性随访长达13年。将空腹血脂成分(甘油三酯[TGs]、高密度脂蛋白胆固醇[HDL-C]、低密度脂蛋白胆固醇[LDL-C]、总胆固醇[TC])作为连续变量进行研究,并报告每个血脂成分每增加一个标准差的结果。将痴呆症发病及其亚型作为删失变量,使用以年龄为时间尺度的Cox模型进行研究。分析对性别、研究中心、教育水平以及血管危险因素和载脂蛋白E(APOE)ε4基因型进行了校正。我们对多重检验进行了校正,得出显著性阈值为0.0169。高于显著性阈值但小于0.05的p值被视为名义上显著。在平均(±SD)7.9±3.6年的随访期内,779名参与者出现了痴呆症发病(n = 532例AD和n = 154例混合型或血管性痴呆)。基线时较高的LDL-C和TC浓度与AD风险增加相关(每增加一个标准差的风险比[HR]=1.13[95%CI 1.04 - 1.22],p = 0.0045;HR = 1.12[1.03 - 1.22],p = 0.0072)。在对血管危险因素进行校正后,这些关联基本不变;在对APOEε4进行校正后,关联减弱(每增加一个标准差的HR = 1.12[1.03 - 1.23],p = 0.0110;HR = 1.12[1.02 - 1.23],p = 0.0171)。基线时较高的TG浓度与所有痴呆症风险增加相关(每增加一个标准差的HR = 1.11[1.03 - 1.19],p = 0.0044)以及混合型或血管性痴呆(HR = 1.21[1.04 - 1.41],p = 0.0163)。然而,在对血管危险因素进行校正后,这些关联消失(HR = 1.07[0.98 - 1.17],p = 0.1374;HR = 1.17[0.96 - 1.42],p = 0.1206)。该研究的主要局限性包括痴呆症发病病例的区间删失、潜在的选择性生存偏差,以及分析中无法考虑随访期间血脂浓度的变化。

结论

在一个对老年社区居民进行长达13年随访的大型基于人群的样本中,我们观察到较高的LDL-C和TC浓度与AD风险增加相关。这一结果独立于血管危险因素,在对APOEε4携带者状态进行校正后减弱。在考虑血管危险因素后,TG和HDL-C浓度与痴呆症发病风险或其亚型无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3244/5369688/88dfe4ee7228/pmed.1002265.g001.jpg

相似文献

2
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study.
Diabetes Care. 2009 Jan;32(1):169-74. doi: 10.2337/dc08-0272. Epub 2008 Oct 22.
3
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
JAMA. 1999 Jul 21;282(3):254-60. doi: 10.1001/jama.282.3.254.
4
Sex differences in the associations between lipid levels and incident dementia.
J Alzheimers Dis. 2013;34(2):519-28. doi: 10.3233/JAD-121228.
5
Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.
Clin Biochem. 2014 Sep;47(13-14):1239-44. doi: 10.1016/j.clinbiochem.2014.03.004. Epub 2014 Mar 21.
6
Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.
Neurology. 2005 Oct 11;65(7):1045-50. doi: 10.1212/01.wnl.0000178989.87072.11.
7
Relation of plasma lipids to Alzheimer disease and vascular dementia.
Arch Neurol. 2004 May;61(5):705-14. doi: 10.1001/archneur.61.5.705.
8
LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
Atherosclerosis. 2016 Aug;251:170-176. doi: 10.1016/j.atherosclerosis.2016.06.029. Epub 2016 Jun 16.
9
Evaluation of the Concurrent Trajectories of Cardiometabolic Risk Factors in the 14 Years Before Dementia.
JAMA Psychiatry. 2018 Oct 1;75(10):1033-1042. doi: 10.1001/jamapsychiatry.2018.2004.
10
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
Neurology. 2005 May 10;64(9):1531-8. doi: 10.1212/01.WNL.0000160114.42643.31.

引用本文的文献

3
Causal cardiovascular risk factors for dementia: insights from observational and genetic studies.
Cardiovasc Res. 2025 May 6;121(4):537-549. doi: 10.1093/cvr/cvae235.
4
6
Primary care biomarkers and dementia in people of the Torres Strait, Australia: extended data analysis.
Front Dement. 2023 Jul 31;2:1218709. doi: 10.3389/frdem.2023.1218709. eCollection 2023.
7
Long-Term High-Fat Diet Impairs AQP4-Mediated Glymphatic Clearance of Amyloid Beta.
Mol Neurobiol. 2025 Jan;62(1):1079-1093. doi: 10.1007/s12035-024-04320-3. Epub 2024 Jul 3.
8
Statins and risks of dementia among patients with heart failure: a population-based retrospective cohort study in Hong Kong.
Lancet Reg Health West Pac. 2024 Jan 17;44:101006. doi: 10.1016/j.lanwpc.2023.101006. eCollection 2024 Mar.
9
The effect of lipid metabolism on age-associated cognitive decline: Lessons learned from model organisms and human.
IBRO Neurosci Rep. 2023 Sep 4;15:165-169. doi: 10.1016/j.ibneur.2023.08.2194. eCollection 2023 Dec.

本文引用的文献

1
Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease.
JAMA Neurol. 2017 Feb 1;74(2):225-232. doi: 10.1001/jamaneurol.2016.3783.
2
Defeating Alzheimer's disease and other dementias: a priority for European science and society.
Lancet Neurol. 2016 Apr;15(5):455-532. doi: 10.1016/S1474-4422(16)00062-4.
3
Incidence of Dementia over Three Decades in the Framingham Heart Study.
N Engl J Med. 2016 Feb 11;374(6):523-32. doi: 10.1056/NEJMoa1504327.
4
Statins for the prevention of dementia.
Cochrane Database Syst Rev. 2016 Jan 4;2016(1):CD003160. doi: 10.1002/14651858.CD003160.pub3.
5
Guidelines for reporting methodological challenges and evaluating potential bias in dementia research.
Alzheimers Dement. 2015 Sep;11(9):1098-109. doi: 10.1016/j.jalz.2015.06.1885.
7
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.
PLoS Med. 2015 Jun 16;12(6):e1001841; discussion e1001841. doi: 10.1371/journal.pmed.1001841. eCollection 2015 Jun.
8
Statins, cognition, and dementia—systematic review and methodological commentary.
Nat Rev Neurol. 2015 Apr;11(4):220-9. doi: 10.1038/nrneurol.2015.35. Epub 2015 Mar 24.
9
Plasma lipids and cerebral small vessel disease.
Neurology. 2014 Nov 11;83(20):1844-52. doi: 10.1212/WNL.0000000000000980. Epub 2014 Oct 15.
10
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.
Lancet Neurol. 2014 Aug;13(8):788-94. doi: 10.1016/S1474-4422(14)70136-X.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验